Mercola.com<\/p>\n
In what one major news source is calling a \u201cmajor blow to vaccine efforts,\u201d two senior FDA officials have suddenly turned in their resignations. Thirty-two year FDA veteran Marion Gruber is leaving her position as director of FDA\u2019s Office of Vaccines Research & Review (OVVR) in October; 10-year employee Phil Krause resigned from his job as deputy director of OVVR. His final work day is in November.<\/p>\n
\u201cThe news, first reported by BioCentury, is a massive blow to confidence in the agency\u2019s ability to regulate vaccines,\u201d Endpoints News said. It\u2019s a \u201chuge global loss,\u201d former BARDA director Rick Bright is reported to have commented.<\/p>\n
According to Endpoints, a former senior FDA leader said \u201cthey\u2019re departing because they\u2019re frustrated that CDC and their ACIP committee are involved in decisions that they think should be up to the FDA \u2026 they\u2019re also \u201cupset with CBER director Peter Marks for not insisting that those decisions should be kept inside FDA. What finally did it for them was the White House getting ahead of FDA on booster shots.\u201d<\/p>\n